XOMA
XOMA Royalty Corporation
NASDAQ: XOMA · HEALTHCARE · BIOTECHNOLOGY
$40.17
+0.00% today
Updated 2026-07-14
Market cap
$792.01M
P/E ratio
28.72
P/S ratio
16.31x
EPS (TTM)
$1.56
Dividend yield
—
52W range
$22 – $45
Volume
0.3M
XOMA Royalty Corporation (XOMA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$40.17
12-Month target
$24.15
2030 Target
—
Intrinsic (DCF)
$14.03
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 12.16% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 69.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.